Guang Zhi Liu

Direttore Tecnico/Scientifico/R&S presso RAINMED MEDICAL LIMITED

44 anni

Consumer Services

Health Technology

Electronic Technology

Profilo

Guang Zhi Liu is currently the Chief Technology Officer at Suzhou Rainmed Medical Technology Co., Ltd.
and Rainmed Medical Ltd.
He completed his undergraduate degree from Shandong University of Technology in 2001.

Posizioni attive di Guang Zhi Liu

Società	Posizione	Inizio
RAINMED MEDICAL LIMITED	Direttore Tecnico/Scientifico/R&S	10/12/2021
Suzhou Rainmed Medical Technology Co., Ltd. Suzhou Rainmed Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Suzhou Rainmed Medical Technology Co., Ltd. is a medical technology company based in Suzhou, China. The Chinese company is dedicated to creating a leading "platform-level" vascular intervention surgical robot and has launched the caFFR, caIMR, and FlashBot vascular intervention surgical robots. The company will continue to adhere to independent innovation, improve the clinical value of its products, create unmanned operating rooms, and promote precision medicine. The company was founded in 2014, and the CEOs are Yun Fei Huo and Yong Hui Lyu.	Direttore Tecnico/Scientifico/R&S	01/09/2020

Tutte le posizioni attive di Guang Zhi Liu

Formazione di Guang Zhi Liu

Shandong University of Technology

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Guang Zhi Liu

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
RAINMED MEDICAL LIMITED	Electronic Technology

Aziende private	1
Suzhou Rainmed Medical Technology Co., Ltd. Suzhou Rainmed Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Suzhou Rainmed Medical Technology Co., Ltd. is a medical technology company based in Suzhou, China. The Chinese company is dedicated to creating a leading "platform-level" vascular intervention surgical robot and has launched the caFFR, caIMR, and FlashBot vascular intervention surgical robots. The company will continue to adhere to independent innovation, improve the clinical value of its products, create unmanned operating rooms, and promote precision medicine. The company was founded in 2014, and the CEOs are Yun Fei Huo and Yong Hui Lyu.	Health Technology